These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2312072)

  • 21. Infants born to HIV infected mothers.
    Thanasophon Y; Na Chiengmai P
    Southeast Asian J Trop Med Public Health; 1992 Mar; 23(1):3-5. PubMed ID: 1523476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sexual behaviors and HIV infection in intravenous drug users in New York City.
    Banks SE; Brown LS; Ajuluchukwu D
    J Addict Dis; 1991; 10(3):15-23. PubMed ID: 1932149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mode of HIV transmission among seroconverted intravenous drug users (IVDUs): 1987 and 1988 cohort study.
    Nemoto T; Brown LS; Primm BJ; Foster K; Chu A
    NIDA Res Monogr; 1989; 95():407-8. PubMed ID: 2641011
    [No Abstract]   [Full Text] [Related]  

  • 24. Risk factors for human immunodeficiency virus infection among parenteral drug abusers in a low-prevalence area.
    Chandrasekar PH; Molinari JA; Kruse JA
    South Med J; 1990 Sep; 83(9):996-1001. PubMed ID: 2402666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV seroconversion in intravenous drug users in San Francisco, 1985-1990.
    Moss AR; Vranizan K; Gorter R; Bacchetti P; Watters J; Osmond D
    AIDS; 1994 Feb; 8(2):223-31. PubMed ID: 8043227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The validity of self-reported HIV antibody test results.
    McCusker J; Stoddard AM; McCarthy E
    Am J Public Health; 1992 Apr; 82(4):567-9. PubMed ID: 1546774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors.
    Neaigus A; Gyarmathy VA; Miller M; Frajzyngier V; Zhao M; Friedman SR; Des Jarlais DC
    Drug Alcohol Depend; 2007 Jul; 89(2-3):234-43. PubMed ID: 17289298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exposure factors for HIV-1 infection among heterosexual drug abusers in New Jersey treatment programs.
    Caussy D; Weiss SH; Blattner WA; French J; Cantor KP; Ginzburg H; Altman R; Goedert JJ
    AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1459-67. PubMed ID: 1964060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioral risk factors and human immunodeficiency virus (HIV) prevalence among intravenous drug users in Puerto Rico.
    Robles RR; Colón HM; Sahai H; Matos TD; Marrero CA; Reyes JC
    Am J Epidemiol; 1992 Mar; 135(5):531-40. PubMed ID: 1570819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human immunodeficiency virus and viral hepatitis seroepidemiology in New York City intravenous drug abusers (IVDAs).
    Brown LS; Kreek MJ; Trepo C; Chu A; Banks SE; Valdes M; Ajuluchukwu D; Phillips R; Primm BJ
    NIDA Res Monogr; 1989; 95():443-4. PubMed ID: 2641023
    [No Abstract]   [Full Text] [Related]  

  • 31. Human immunodeficiency virus infection and syphilis in Hondurian female prostitutes.
    Venegas VS; Madrid JP; Lorenzana I; Grillner L; Cosenza H; Bygdeman S
    Int J STD AIDS; 1991; 2(2):110-3. PubMed ID: 2043701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. The National AIDS Research Consortium.
    Friedman SR; Jose B; Deren S; Des Jarlais DC; Neaigus A
    Am J Epidemiol; 1995 Oct; 142(8):864-74. PubMed ID: 7572963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [HIV seroprevalence in patients seen at sexually-transmitted disease and family planning centers in Spain, 1995-1996. AIDS Programs of the Autonomic Communities and Network of sexually-transmitted disease, HIV and family planning centers].
    Rev Esp Salud Publica; 1999; 73(1):25-34. PubMed ID: 10224878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AIDS-related illness and AIDS risk in male homo/bisexual substance abusers: case reports and clinical issues.
    Westermeyer J; Seppala M; Gasow S; Carlson G
    Am J Drug Alcohol Abuse; 1989; 15(4):443-61. PubMed ID: 2596446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparations for AIDS vaccine trials. Retention, behavior change, and HIV-seroconversion among injecting drug users (IDUs) and sexual partners of IDUs.
    Marmor M; Titus S; Wolfe H; Krasinski K; Maslansky R; Simberkoff M; Beatrice S; Nichols S; Des Jarlais DC
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S207-13. PubMed ID: 7865302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective evaluation of a model of risk for HIV infection among injecting drug users.
    Iguchi MY; Bux DA; Kushner H; Lidz V; French JF; Platt JJ
    Drug Alcohol Depend; 1995 Nov; 40(1):63-71. PubMed ID: 8746926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV counseling and testing among injection drug users needs to continue.
    Beckwith CG; Zaller N; Flanigan TP
    Am J Public Health; 2007 Jul; 97(7):1161. PubMed ID: 17538046
    [No Abstract]   [Full Text] [Related]  

  • 38. Incidence of HIV among injection drug users entering drug treatment programs in four US cities.
    Murrill CS; Prevots DR; Miller MS; Linley LA; Royalty JE; Gwinn M;
    J Urban Health; 2001 Mar; 78(1):152-61. PubMed ID: 11368194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV infection among women in prison: an assessment of risk factors using a nonnominal methodology.
    Hankins CA; Gendron S; Handley MA; Richard C; Tung MT; O'Shaughnessy M
    Am J Public Health; 1994 Oct; 84(10):1637-40. PubMed ID: 7943484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Death, AIDS morbidity, and HIV seroprevalence in New York City intravenous drug abusers.
    Burkett W; Brown LS
    J Natl Med Assoc; 1990 Nov; 82(11):777-80. PubMed ID: 2258951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.